ARTICLE | Company News
Schwarz, AmorePacific pain deal
February 20, 2004 8:00 AM UTC
Schwarz Pharma (Monheim, Germany) received exclusive global rights to develop, market and manufacture AmorePacific's PAC20030 vanilloid receptor 1 ( VR1) antagonist and back-up compounds to treat pain...